LOGIN
Efficacy of a cannabis-based oromucosal spray in managing peripheral neuropathic pain
September 2018
Efficacy of a cannabis-based oromucosal spray in managing peripheral neuropathic pain
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A
A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment
Eur J Pain. 2014 Aug;18(7):999-1012. doi: 10.1002/j.1532-2149.2013.00445.xDid you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
303 patients with peripheral neuropathic pain (PNP) were randomized to either Nabiximols or placebo for 14 weeks. Significant improvements in pain, quality of sleep and Subject Global Impression of Change (SGIC) were found in patients that received Nabiximols compared to those that received placebo. No patients experienced severe treatment-related adverse events in the Sativex group versus one in ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.